Abstract:Objective:Many genotypes of mutation and different phenotypes has been described in patients with Alport syndrome(AS) characterized by changes subchains of type Ⅳ collagen along the glomerular basement membrane(GBM). And in some of the patients, staining of GBM with antibodies to collagen subchains appeared positive/normal under immunohistochemistry studies. In this study, we studied such kind of atypical AS cases by quantitatively analyzed type Ⅳ collagen alpha 3 and alpha 5 chains in GBM, as to disclose the molecular pathogenesis of the disease and to provide a new method to diagnose these atypical AS. Methodology:This study involved 14 AS patients whose diagnosis were based on clinical feature,pathologic findings and electron microscopy study. All of them were positive for routine staining of subchains of type Ⅳ collagen. Immunofluorescence double staining and confocal microscopy were used to quantitatively determine the ratio of staining signal for α3(Ⅳ) or α5(Ⅳ) to Ⅳ along GBM. Four patients with thin basement membranous nephropathy (TBMN) and ten patients with mild mesangial proliferative glomerulonephritis (MsPGN) were used as the controls. Results:The GBM defect was the prominent finding under electron microscopy. Compared to MsPGN patients in the control group, the ratio of α3(Ⅳ)or α5(Ⅳ) to Ⅳ decreased significantly( P0 05, P0 01 vs MsPGN). Based on the results of quantitative analysis, patients were divided into three groups: Group 1, patients with reduced α5(Ⅳ)/Ⅳ but normal α3(Ⅳ) /Ⅳ. This group included 1 male and 1 female. Neither of them had positive family history of renal diseases. Group 2, patients with simultaneously reduced α5(Ⅳ)/Ⅳ and α3(Ⅳ) /Ⅳ. This group included 3 males and 6 females. Study of family history demonstrated most of the patients were X linked. Group 3, patients with normal α5(Ⅳ)/Ⅳ and α3(Ⅳ) /Ⅳ. This group included 1females and 2 males. Study of family history demonstrated most of the patients were X linked. Furthermore, we found that the reduced α5(Ⅳ)/Ⅳ correlated with proteinuria, which reflected the severity of glomerular involvement. Unlike AS, none of four patients with TBMN had decreases of α3(Ⅳ) /Ⅳ or α5(Ⅳ) /Ⅳ. Conclusion:Although the staining of subchains of type Ⅳ collagen along the GBM in some patients with AS looked like normal, the compositions of type Ⅳ collagen had altered and characterized by the decreased ratio of α3(Ⅳ)/Ⅳ or α5(Ⅳ)/Ⅳ. By applying this quantitative analysis, a new approach is available to the diagnosis of atypical AS cases. Data of this quantitative analysis is of clinical value for future classification of the genotypes and phenotypes of AS patients, and for the prognosis of these patients.

Siblings with Alport’s syndrome showing unique staining patterns for α5(IV) and α6(IV) chains of collagen type IV

Quantitative Analysis of Type IV Collagen Subchains in the Glomerular Basement Membrane of Patients with Alport Syndrome with Confocal Microscopy.

X-linked Alport syndrome presenting in mother and son with the same unique histopathological features

Alport Syndrome With a Rare Collagen Type IV Alpha-4 (COL4A4) Gene Mutation: A Case Report

A Pedigree with COL4A5 Mutation Presenting with Alport Syndrome and Focal Segmental Glomerulosclerosis Lesions: a Case Report.

Pathological diagnosis of Alport syndrome

Genetic diagnosis of Alport syndrome in 16 Chinese families

A novel COL4A5 splicing mutation causes alport syndrome in a Chinese family

Quantitative Analysis of Type Ⅳ Collagen Alpha 3 and Alpha 5 Chain in the Glomerular Basement Membrane in Patients with Alport Syndrome

[Analysis of Alport Syndrome Induced by Type IV Collagen Alpha 5 Gene Mutation in Two Families].

Features of Phenotype and Genotype in Chinese Alport Syndrome Patients

Four novel mutations identified in the COL4A3, COL4A4 and COL4A5 genes in 10 families with Alport syndrome

[Features of Clinical Phenotype and Genotype in Alport Syndrome: a Monocentric Study].

Clinical and genetic features of X-linked Alport syndrome in men positive for the collagen Ⅳ α5 chain in epidermal basement membrane]

Novel Digenic Variants in COL4A4 and COL4A5 Causing X-Linked Alport Syndrome: A Case Report

[Clinical and Pathological Study of 47 Cases with Alport Syndrome].

A Novel COL4A5 Pathogenic Variant Joins the Dots in a Family with a Synchronous Diagnosis of Alport Syndrome and Polycystic Kidney Disease

Novel COL4A3 synonymous mutation causes Alport syndrome coexistent with immunoglobulin A nephropathy in a woman: A case report

The First COL4A5 Exon 41A Glycine Substitution in a Family with Alport Syndrome

Alport syndrome and Alport kidney diseases – elucidating the disease spectrum

Spectrum of clinical features and type IV collagen α-chain distribution in Chinese patients with Alport syndrome